Precision Medicine Market Report 2026

Precision Medicine Market Overview

• Precision Medicine market size has reached to $87.91 billion in 2025 • Expected to grow to $137.69 billion in 2030 at a compound annual growth rate (CAGR) of 9.4% • Growth Driver: Rising Cancer Prevalence Propels Growth In The Precision Medicine Market • Market Trend: Artificial Intelligence-Powered Solutions Enhance Drug Discovery And Precision Medicine • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

The key promising market opportunities in the precision medicine market include: • Gene Sequencing (Segmentation By Technology) → Expected gain of $14.21 Billion • Drug Discovery (Segmentation By Technology) → Expected gain of $13.15 Billion • Bioinformatics (Segmentation By Technology) → Expected gain of $10.48 Billion

What Is Covered Under Precision Medicine Market?

Precision medicine refers to a type of medication that prevents, detects, or treats disease using knowledge about a person's genes or proteins. To choose a treatment that may be most effective for a person, precision medicine considers their genetics, environment, and lifestyle. The main technologies involved in precision medicine are bioinformatics, big data analytics, drug discovery, gene sequencing, companion diagnostics, and others. Bioinformatics technologies involve the application of computational tools to organize, analyze, understand, visualize, and store information associated with biological macromolecules. It is used in oncology, respiratory diseases, central nervous disorders, immunology, genetic diseases, and others and is implemented in various sectors such as pharmaceuticals, diagnostic companies, healthcare, and IT firms, among others.

What Is The Precision Medicine Market Growth Forecast?

The precision medicine market size is expected to see strong growth in the next few years. It will grow to $137.69 billion in 2030 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to expansion of next-generation sequencing adoption, rising demand for personalized treatment plans, growing use of ai-driven drug discovery, increasing investments in precision diagnostics, integration of digital health platforms. Major trends in the forecast period include rising adoption of companion diagnostics, shift toward personalized oncology therapies, integration of multi-omics data in clinical decision-making, expansion of precision medicine in rare and genetic diseases, increasing collaboration between pharma and diagnostic firms.

What Is The Driver Of The Precision Medicine Market?

The rising prevalence of cancer is projected to fuel the growth of the precision medicine market. Cancer is one of the main causes of death worldwide, with one out of every five individuals developing cancer at some point in their lives. Precision medicine in cancer entails analyzing DNA from tumors to find mutations or other genetic abnormalities that cause cancer. Physicians may therefore be able to choose a treatment for a specific patient's cancer that best fits, or targets, the tumor DNA alterations. For instance, in February 2024, according to the World Health Organization, a Switzerland-based specialized agency responsible for international public health, by 2050, over 35 million new cancer cases are projected, representing a 77% increase from the estimated 20 million cases in 2022. Therefore, the rising prevalence of cancer drives the growth of the precision medicine industry.

How Will The Drivers Impact Growth In The Global Precision Medicine Market?

• Rising Adoption Of Genomic Sequencing Technologies (High) – During the forecast period, the rising adoption of genomic sequencing technologies is expected to become a key growth driver for the precision medicine market by 2030. Rising adoption of genomic sequencing technologies is accelerating the growth of precision medicine by reducing sequencing costs, improving accessibility, and enabling detailed analysis of individual genetic profiles. These advanced sequencing technologies are supporting personalized diagnosis, early disease detection, and the development of targeted therapies across oncology, rare diseases, and inherited disorders. The integration of next-generation sequencing (NGS), whole-genome sequencing, and molecular profiling is helping healthcare providers identify genetic variations, optimize treatment strategies, and improve patient outcomes through more accurate and data-driven medical interventions. • Increasing Prevalence Of Chronic And Genetic Diseases (Medium) – During the forecast period, the increasing prevalence of chronic and genetic diseases is expected to emerge as a major factor driving the expansion of the precision medicine market by 2030. Increasing prevalence of chronic and genetic diseases is driving demand for individualized treatments, biomarker-based diagnostics, and personalized therapeutic approaches across cancer, cardiovascular disorders, and inherited conditions. The growing burden of complex diseases is increasing the need for advanced diagnostic tools that can identify disease-specific genetic markers and guide effective treatment selection. Precision medicine approaches enable healthcare professionals to develop targeted therapies based on patient-specific characteristics, improving treatment effectiveness, reducing unnecessary therapies, and supporting long-term disease management. • Integration Of Artificial Intelligence In Healthcare (Medium) – During the forecast period, the integration of artificial intelligence in healthcare is expected to act as a key growth catalyst for the precision medicine market by 2030. Integration of artificial intelligence in healthcare is improving genomic data analysis, predictive diagnostics, and treatment selection by enabling faster interpretation of complex biological datasets. AI-driven platforms help analyze genetic information, identify disease-associated mutations, discover potential biomarkers, and predict patient responses to specific therapies. The combination of artificial intelligence with genomics, clinical data, and real-world evidence is enhancing clinical decision-making, accelerating drug discovery, and strengthening precision-based healthcare outcomes through more accurate and personalized interventions.

How Will The Restraints Impact Growth In The Global Precision Medicine Market?

• High Cost Of Precision Medicine Treatments (High) – During the forecast period, the high Cost Of Precision Medicine Treatments limits patient accessibility due to expensive genomic testing, targeted therapies, and advanced diagnostic infrastructure requirements in healthcare systems. • Data Privacy And Security Concerns (Medium) – During the forecast period, the data Privacy And Security Concerns restrict adoption because precision medicine relies heavily on sensitive genomic and patient health information requiring strict regulatory compliance and cybersecurity protection. • Limited Clinical Infrastructure And Skilled Professionals (Medium) – During the forecast period, the limited Clinical Infrastructure And Skilled Professionals slows precision medicine implementation due to inadequate genomic testing facilities and shortage of trained bioinformatics and genetic experts.

Key Players In The Global Precision Medicine Market

Major companies operating in the precision medicine market are Quest Diagnostics, Thermo Fisher Scientific Inc., Roche Holding AG, Medtronic plc, Novartis AG, Pfizer Inc., Qiagen, AstraZeneca plc., Abbott Laboratories, Nordic Bioscience A/S, Takeda Pharmaceutical Company Ltd., Otsuka Pharmaceutical Co. Ltd., Daiichi Sankyo, China National Pharmaceutical Group Co. Ltd., GE Healthcare, Randox Laboratories, Almac Group, Sun Pharma, Nichi-Iko Pharmaceutical Co. Ltd., Daewoong Pharmaceutical Co.Ltd, GlaxoSmithKline, Teva UK Limited, Vectura Group, Merck & Co., Boehringer Ingelheim, Mylan, Zentiva, Sanofi, Apotex, Gilead Sciences, Bayer, AbbVie Inc., Amgen, Janssen Pharmaceutica, Accord Healthcare Inc., Acerus Precision Medicine Corporation, AA Pharma Inc, Sanfer, LABORATORIOS SENOSIAIN SA DE CV, Siegfried Rhein, Biocrates LifeSciences, Nanostring Technologies, Tepnel Pharma Services, Intomics, Silicon Biosystems, EMS Pharma, Eurofarma, Biolab Farmaceutica, Cristalia, União Quimica

Global Precision Medicine Market Trends and Insights

Major companies operating in the precision medicine market are focusing on innovation, such as data ingestion, which facilitates access to public datasets through Google Cloud's Analytics Hub. Data ingestion is the process of collecting and importing data from various sources into a storage system or a data processing platform. For instance, in May 2023, Google Cloud, a US-based software development company, launched two innovative AI-powered solutions aimed at enhancing drug discovery and precision medicine. New AI-powered solutions are helping accelerate drug discovery and precision medicine for the biotech and pharmaceutical industries. Researchers can now identify protein structures and interpret genomic data more efficiently, improving drug development processes. These tools reduce time-to-market for life-saving treatments and enhance collaboration among research teams. They also support multi-cloud environments for seamless integration.

What Are Latest Mergers And Acquisitions In The Precision Medicine Market?

In July 2024, Thermo Fisher Scientific Inc., a US-based biotechnology company, acquired Olink Proteomics for an undisclosed amount. This acquisition aims to expand its capabilities in proteomics, a growing field focused on the large-scale study of proteins. Olink Proteomics is a Sweden-based biotechnology research company contributing to precision medicine through its innovative technologies and services focused on protein biomarker analysis.

What Defines the Precision Medicine Market?

The precision medicine market consists of sales of imatinib, personalized medicine, and individualized medicine. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Precision Medicine Market Report 2026?

The precision medicine market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the precision medicine industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.